Welby Corporation

Welby Corporation

The company will continue to create digital health solutions that help patients get the best medical care through apps, web services, and data management.

HQ location
Tokyo, Japan
Website
Launch date
Market cap
$21.6m
Enterprise value
$19m
Share price
JPY339.00 4438.T
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

N/A

IPO
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
JPY201920202021202220232024
Revenues000000000000000000000000
% growth-8 %32 %(8 %)(45 %)(8 %)
EBITDA000000000000000000000000
% EBITDA margin1 %(25 %)(10 %)7 %(76 %)(120 %)
Profit000000000000000000000000
% profit margin(1 %)(41 %)(11 %)3 %(88 %)(152 %)
EV000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000

Source: Company filings or news article

Notes (0)
More about Welby Corporation
Made with AI
Edit

Welby Inc., established in September 2011 by Takeru Hiki, operates as a key player in Japan's digital health sector. Hiki, who previously served as COO at MedPeer, Inc., a networking site for physicians, founded Welby to pioneer the social implementation of Personal Health Record (PHR) services in the country. The company's vision is to create a society where patients can access their medical information anytime and anywhere, empowering them to take an active role in their treatment.

The core of Welby's business is its PHR platform, which allows individuals and their families to record, store, and share personal health data with medical professionals. This platform underpins a suite of digital health solutions and mobile applications tailored for various diseases, including diabetes, lifestyle-related illnesses, mental illness, oncology, and rare diseases. The company launched its first service, "Welby My Chart" (formerly Welby Diabetes), in 2011 to support patients with conditions like lifestyle-related diseases.

Welby's business model is centered on co-developing and providing these digital services in collaboration with a range of clients, including pharmaceutical companies, medical device manufacturers, healthcare professionals, and government bodies. This collaborative approach extends to supporting marketing, promotion, and data analysis for its partners in the medical industry. A notable partnership includes a strategic alliance with AstraZeneca to jointly release an application supporting cancer patients with medication management. Revenue is generated through these collaborations and the provision of its platform services.

Significant milestones in Welby's history include a capital and business tie-up with Digital Garage and the Japan Post Group in 2017. The company went public in March 2019, listing on the Tokyo Stock Exchange Mothers market (now Growth). More recently, Welby has engaged in business alliances with Chubu Electric Power and Suzuken Co., Ltd. to further develop and disseminate PHR services and medical DX platforms, including acquiring a majority stake in MeDaCa (Medical Data Card Inc.).

Keywords: Personal Health Record, PHR, digital health, healthcare IT, patient engagement, chronic disease management, mobile health, eHealth, medical data platform, Welby My Chart, Takeru Hiki, pharmaceutical collaboration, medical device integration, patient support program, clinical trial support, lifestyle disease management, oncology support, Japan healthcare, medical DX, MedPeer

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Welby Corporation

Edit